Dopaminephilic properties of ergot alkaloids.
D000097:Acetonitriles / Q000627:therapeutic use; D000818:Animals; D001971:Bromocriptine / Q000627:therapeutic use; D003342:Corpus Striatum / Q000378:metabolism; D004873:Ergolines / Q000627:therapeutic use; D004876:Ergot Alkaloids / Q000378:metabolism / Q000627:therapeutic use*; D000882:Haplorhini; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000378:metabolism; D013134:Spiperone / Q000378:metabolism; D013378:Substantia Nigra / Q000378:metabolism; D013574:Synaptosomes / Q000201:enzymology; D014202:Tremor / Q000188:drug therapy; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D000097:Acetonitriles; D004873:Ergolines; D004876:Ergot Alkaloids; D011954:Receptors, Dopamine; D001971:Bromocriptine; D007980:Levodopa; D013134:Spiperone; D014446:Tyrosine 3-Monooxygenase